Understanding Your Cancer’s Genetic Blueprint
When facing a cancer diagnosis, understanding the specific genetic drivers of your tumour can be the key to more effective, targeted treatment. The OncoPro Focus Fusion Panel provides this crucial insight, analysing over 50 cancer biomarkers to help guide your treatment journey with precision and confidence.
What This Test Reveals About Your Cancer
The OncoPro Focus Fusion Panel uses advanced next-generation sequencing technology to examine the genetic makeup of your solid tumour. Unlike traditional methods that might miss important genetic changes, this comprehensive panel simultaneously analyses multiple genes known to drive cancer growth and progression.
Think of it as reading your cancer’s instruction manual – by understanding which genetic switches are turned on or off, your oncologist can recommend treatments that specifically target those abnormalities, potentially leading to better outcomes with fewer side effects.
Who Should Consider This Genetic Cancer Test
This test is particularly valuable for patients who:
- Have been diagnosed with lung, breast, colorectal, or other solid tumours
- Are seeking targeted therapy options beyond standard chemotherapy
- Have cancer that has returned or stopped responding to current treatment
- Want to understand their eligibility for clinical trials
- Desire comprehensive genetic information for personalised treatment planning
If you’re feeling overwhelmed by treatment decisions or wondering if there are more targeted options available, this test can provide the clarity you need.
Why Genetic Testing Matters for Your Cancer Journey
Knowing your tumour’s genetic profile offers several important benefits:
- Personalised Treatment: Identify which targeted therapies are most likely to work for your specific cancer type
- Avoid Unnecessary Treatment: Prevent spending time and resources on treatments that may not be effective
- Clinical Trial Access: Discover eligibility for cutting-edge treatments and research studies
- Peace of Mind: Make treatment decisions based on comprehensive genetic information rather than guesswork
- Better Outcomes: Targeted therapies often work more effectively with fewer side effects than traditional chemotherapy
Understanding Your Test Results
Your results will provide a detailed report showing which genetic mutations are present in your tumour. Our team ensures that the findings are presented clearly, with explanations about what each result means for your treatment options.
Your oncologist will review the results with you, discussing:
- Which targeted therapies match your genetic profile
- Potential treatment effectiveness based on your specific mutations
- Any clinical trial opportunities that align with your results
- Next steps in your treatment journey
Remember, genetic information is powerful – it gives you and your healthcare team more control over your treatment path.
Investment in Your Health Journey
| Service | Regular Price | Special Price |
|---|---|---|
| OncoPro Focus Fusion Panel | ZAR 13,650 |
Consider this: The cost of ineffective treatment or delayed response can far exceed the investment in genetic testing. This comprehensive panel analyses 50+ biomarkers in a single test, providing value that could guide years of effective treatment.
Why Trust Oracle Genomics
With testing centres across South Africa including Johannesburg, Cape Town, Durban, and Pretoria, we bring advanced genetic testing closer to home. Our commitment includes:
- 99.9% Accuracy: Advanced next-generation sequencing technology
- Expert Analysis: Results reviewed by experienced molecular pathologists
- Quick Turnaround: Results within 15 working days from sample receipt
- Nationwide Coverage: Accessible testing across major South African cities
- Patient Support: Clear explanations and guidance throughout the process
Take Control of Your Cancer Treatment Today
Don’t leave your treatment decisions to chance. Understanding your cancer’s genetic profile could be the turning point in your journey toward more effective, targeted care.
Sample Requirements: We require a formalin-fixed paraffin-embedded (FFPE) tissue block with at least 10% tumour tissue. Samples are shipped at room temperature.
Turnaround Time: Submit samples by Monday 11:00 AM for results within 15 working days.
Early genetic testing can lead to earlier targeted intervention. Don’t wait – take the first step toward personalised cancer care today.
